These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1838817)

  • 1. [Association of cardiovascular risk factors in hypertensive patients with left ventricular hypertrophy].
    Laviades C; Mayor G; Díez J
    Rev Clin Esp; 1991 Dec; 189(9):403-7. PubMed ID: 1838817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular hypertrophy in patient on dialysis].
    Lovcić V; Sebetić D; Klobucić M; Kusec V
    Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG; Omotoso AB; Akande AA
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O; Inal V; Baysan O; Sağlam K
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence, characteristics and clinical correlates of left ventricular hypertrophy in stable hypertension. Echocardiographic study].
    Lusiani L; Ronsisvalle G; Nogarin L; Bonanome A; Nicolin P; Visonà A; Castellani V; Pagnan A; Sisini M; Pigato R
    G Ital Cardiol; 1987 Mar; 17(3):220-8. PubMed ID: 2956149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
    Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
    Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevalence of cardiovascular risk factors in a population of essential hypertension patients].
    Gavaldà L; Ramón JM; Torras MG; Martínez Amenós A; Rama H; Sarrias X
    Rev Esp Cardiol; 1993 Oct; 46(10):626-32. PubMed ID: 8234997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients.
    Aguilera A; Bajo MA; Rebollo F; Díez JJ; Díaz C; Paiva A; Codoceo R; Selgas R
    Adv Perit Dial; 2002; 18():212-7. PubMed ID: 12402621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.